Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Division of Cardiovascular Medicine, Scripps Clinic, La Jolla, California.
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):109-120. doi: 10.1016/j.jcmg.2018.08.025. Epub 2018 Oct 17.
This study aimed to evaluate the long-term prognostic value of serial assessment of coronary flow reserve (CFR) by rubidium Rb 82 (Rb) positron emission tomography (PET) in heart transplantation (HT) patients.
Cardiac allograft vasculopathy is a major determinant of late mortality in HT recipients. The long-term prognostic value of serial CFR quantification by PET imaging in HT patients is unknown.
A total of 89 patients with history of HT (71% men, 7.0 ± 5.7 years post-HT, age 57 ± 11 years) scheduled for dynamic rest and stress (dipyridamole) Rb PET between March 1, 2008 and July 31, 2009 (PET-1) were prospectively enrolled in a single-center study. PET myocardial perfusion studies were reprocessed using U.S. Food and Drug Administration-approved software (Corridor 4DM, version 2017) for calculation of CFR. Follow-up PET (PET-2) imaging was performed in 69 patients at 1.9 ± 0.3 years following PET-1. Patients were categorized based on CFR values considering CFR ≤1.5 as low and CFR >1.5 as high CFR.
Forty deaths occurred during the median follow-up time of 8.6 years. Low CFR at PET-1 was associated with a 2.77-fold increase in all-cause mortality (95% confidence interval [CI]: 1.34 to 5.74; p = 0.004). CFR decreased over time in patients with follow-up imaging (PET-1: 2.11 ± 0.74 vs. PET-2: 1.81 ± 0.61; p = 0.003). Twenty-five patients were reclassified based on PET-1 and PET-2 (high to low CFR: n = 18, low to high CFR: n = 7). Overall survival was similar in patients reclassified from high to low as patients with low to low CFR, whereas patients reclassified from low to high had similar survival as patients with high to high CFR. In multivariate Cox regression of patients with PET-2, higher baseline CFR (hazard ratio [HR] for a 0.73 unit (one SD) increase: 0.36, 95% CI: 0.16 to 0.82) and reduction in CFR from PET-1 to PET-2 (HR for a 0.79 unit (one SD) decrease: 1.50 to 7.84) were independent predictors of all-cause mortality.
Serial assessment of CFR by Rb PET independently predicts long-term mortality in HT patients.
本研究旨在评估放射性核素铷 82(Rb)正电子发射断层扫描(PET)连续评估冠状动脉血流储备(CFR)在心脏移植(HT)患者中的长期预后价值。
心脏移植受者的心脏移植物血管病是晚期死亡的主要决定因素。HT 患者通过 PET 成像连续定量 CFR 的长期预后价值尚不清楚。
2008 年 3 月 1 日至 2009 年 7 月 31 日期间,共 89 例有 HT 病史的患者(71%为男性,HT 后 7.0±5.7 年,年龄 57±11 岁)被前瞻性纳入单中心研究,接受动态静息和应激(双嘧达莫)Rb PET 检查。使用美国食品和药物管理局批准的软件(Corridor 4DM,版本 2017)重新处理 PET 心肌灌注研究,以计算 CFR。在 PET-1 后 1.9±0.3 年,对 69 例患者进行了随访 PET(PET-2)成像。根据 CFR 值将患者分为 CFR≤1.5 为低 CFR 和 CFR>1.5 为高 CFR。
中位随访时间为 8.6 年,期间有 40 例死亡。PET-1 时低 CFR 与全因死亡率增加 2.77 倍相关(95%置信区间[CI]:1.34 至 5.74;p=0.004)。有随访成像的患者 CFR 随时间下降(PET-1:2.11±0.74 与 PET-2:1.81±0.61;p=0.003)。根据 PET-1 和 PET-2,有 25 例患者重新分类(高到低 CFR:n=18,低到高 CFR:n=7)。从高到低重新分类的患者与低到低 CFR 的患者的总体生存率相似,而从低到高重新分类的患者与高到高 CFR 的患者的生存率相似。在有 PET-2 的患者的多变量 Cox 回归中,基线 CFR 较高(每增加 0.73 单位(一个标准差)的风险比[HR]:0.36,95%CI:0.16 至 0.82)和从 PET-1 到 PET-2 的 CFR 降低(每减少 0.79 单位(一个标准差)的 HR:1.50 至 7.84)是全因死亡率的独立预测因素。
Rb PET 连续评估 CFR 可独立预测 HT 患者的长期死亡率。